Recent Security Class Actions

Immutep Limited American Depositary Shares (NASDAQ: IMMP)

Company Name:Immutep Limited American Depositary Shares
Stock Symbol:NASDAQ: IMMP
Class Period Start:03/24/2025
Class Period End (inclusive):03/12/2026
Filing Deadline:07/06/2026

The complaint alleges Defendants provided investors with material information concerning Immutep’s TACTI-004 Phase III trial evaluating eftilagimod alfa (efti) in patients with advanced lung cancer. Defendants’ statements included, among other things, Immutep’s positive assertions of TACTI004’s future trial success based on continuing positive efficacy and safety readouts, particularly following positive top-line results from Immutep’s prior TACTI-002 and INSIGHT-003 studies.